Literature DB >> 9729367

Immunohistochemical analysis of transferrin receptor: regional and cellular distribution in the hypotransferrinemic (hpx) mouse brain.

T K Dickinson1, J R Connor.   

Abstract

The hypotransferrinemic (hpx) mouse mutant produces <1% of the normal circulating level of transferrin (Tf). Heterozygote animals of this strain (hpx/+) have approximately 50% of normal plasma Tf levels. In this study we examine the cellular and regional distribution of Tf receptor (Tf-R) in the brain of wild type, hpx/+ and mutant (hpx/hpx) mice. Also, using slot-blot (immunoblot) analysis, we describe the relative amount of Tf-R in brain microvessels of hpx/+ animals compared with wild type. Tf-R was seen primarily in neurons throughout the brains of wild type, hpx/+ and hpx/hpx animals. Gray matter areas immunoreacted more robustly than white matter areas. Oligodendrocytes and third ventricle tanycytes, both of which we have previously described as iron-positive, did not immunoreact for Tf-R. Tf-R immunohistochemical reaction in wild type, hpx/+ and hpx/hpx brains appeared similar. Immunoblot analysis of isolated cortical microvessels from wild type and hpx/+ animals revealed no upregulation of Tf-R expression in hpx/+ (relative to normal) despite a 50% decrease in circulating Tf levels. These results indicate that Tf-R is primarily expressed by neurons and that half normal levels of Tf (hpx/+) or transferrin supplementation (hpx/hpx) are apparently sufficient for normal expression and distribution of Tf-R. Because of the lack of circulating Tf, but unaltered Tf-R expression, hpx mice could serve as a model for delivery of therapeutic agents via the Tf/Tf-R system. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729367     DOI: 10.1016/s0006-8993(98)00575-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Apotransferrin protects cortical neurons from hemoglobin toxicity.

Authors:  Jing Chen-Roetling; Lifen Chen; Raymond F Regan
Journal:  Neuropharmacology       Date:  2010-10-27       Impact factor: 5.250

Review 2.  The use of hypotransferrinemic mice in studies of iron biology.

Authors:  Julia T Bu; Thomas B Bartnikas
Journal:  Biometals       Date:  2015-02-08       Impact factor: 2.949

3.  Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types.

Authors:  J A Lockman; W J Geldenhuys; K A Bohn; S F Desilva; D D Allen; C J Van der Schyf
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

4.  Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures.

Authors:  Julie A Gaasch; Werner J Geldenhuys; Paul R Lockman; David D Allen; Cornelis J Van der Schyf
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 3.996

5.  Towards a translational physiologically-based pharmacokinetic (PBPK) model for receptor-mediated transcytosis of anti-transferrin receptor monoclonal antibodies in the central nervous system.

Authors:  Hsueh-Yuan Chang; Shengjia Wu; Ekram Ahmed Chowdhury; Dhaval K Shah
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-01-29       Impact factor: 2.745

6.  Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene.

Authors:  Ana G Barbeito; Holly J Garringer; Martin A Baraibar; Xiaoying Gao; Miguel Arredondo; Marco T Núñez; Mark A Smith; Bernardino Ghetti; Ruben Vidal
Journal:  J Neurochem       Date:  2009-03-30       Impact factor: 5.372

Review 7.  The Aging of Iron Man.

Authors:  Azhaar Ashraf; Maryam Clark; Po-Wah So
Journal:  Front Aging Neurosci       Date:  2018-03-12       Impact factor: 5.750

8.  Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis.

Authors:  Hsueh-Yuan Chang; Shengjia Wu; Yingyi Li; Wanying Zhang; Matthew Burrell; Carl I Webster; Dhaval K Shah
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 9.  Role of endolysosome function in iron metabolism and brain carcinogenesis.

Authors:  Peter W Halcrow; Miranda L Lynch; Jonathan D Geiger; Joyce E Ohm
Journal:  Semin Cancer Biol       Date:  2021-06-15       Impact factor: 15.707

10.  Abnormal brain iron metabolism in Irp2 deficient mice is associated with mild neurological and behavioral impairments.

Authors:  Kimberly B Zumbrennen-Bullough; Lore Becker; Lillian Garrett; Sabine M Hölter; Julia Calzada-Wack; Ilona Mossbrugger; Leticia Quintanilla-Fend; Ildiko Racz; Birgit Rathkolb; Thomas Klopstock; Wolfgang Wurst; Andreas Zimmer; Eckhard Wolf; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Steven J Romney; Elizabeth A Leibold
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.